09:53 AM EST, 11/21/2024 (MT Newswires) -- Telomir Pharmaceuticals ( TELO ) said Thursday that a preclinical study showed "significant" age reversal effects in subjects treated with Telomir-1, a compound designed to reverse aging and support longevity.

Among the effects were increased lifespan, improved mobility, and a measurable reversal of biological age markers, according to Telomir.

The company said it is collaborating with the Progeria Foundation to evaluate the effects of Telomir-1 on human progeria cell lines to advance the development of the compound as a potential treatment for children with progeria, a genetic disorder that causes accelerated aging.

Shares of Telomir Pharmaceuticals ( TELO ) rose more than 12% in early trading Thursday.

Price: 4.74, Change: +0.54, Percent Change: +12.86